InBios International Inc., a leading developer of diagnostics for infectious diseases, announced that the U.S. Department of Health and Human Services (HHS) and the Cohen Foundation have awarded the company $100,000 as a Phase 1 winner in the LymeX Diagnostics Prize competition.(PRWeb November 15, 2022)Read the full story at https://www.prweb.com/releases/2022/11/prweb19021200.htm